Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!
Skip to content
Cocktail Whisperer
CEO:Klaus Author/Chef/Barman/Cannabis Alchemist/Master Mixologist Forbes Vices SXSW Cannabis Disruptor Berlin Bar Convent-Cannabis Moscow Bar Show-Master Class-Rum
Primary Navigation Menu
Menu
  • Warren Bobrow
  • Klaus!
  • Order via Amazon
  • Order via Barnes & Noble
  • Order via Quarto Books
  • News
  • Articles

DNA-based pathogen testing

Revolutionary Company PathogenDx Announces $7.5 Million In Series B Funding

2019-10-05
By: Warren_Bobrow
On: October 5, 2019
In: Forbes, Interviews

TweetPathogenDx, Inc., an innovator in DNA-based pathogen testing technology for cannabis, hemp, agriculture and food safety industries, announced Monday it has secured $7.5 million in Series B funding. The company was able to close this round of funding in just under three months. Read More Here At Forbes:Continue Reading

Designed using Unos. Powered by WordPress.